Cwm, LLC Care Dx, Inc. Transaction History

Cwm, LLC

$24.1 Billion
Q4 2024

A detailed history of Cwm, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Cwm, LLC holds 10,094 shares of CDNA stock, worth $195,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,094

Previous 7,604 32.75%

Holding current value

$195,016

Previous $237,000 8.86%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$20.4 - $32.2 $50,796 - $80,178	2,490 Added 32.75%	10,094 $216,000
Q3 2024 Oct 08, 2024	BUY	$14.41 - $33.99 $92,973 - $219,303	6,452 Added 560.07%	7,604 $237,000
Q2 2024 Jul 09, 2024	SELL	$7.56 - $16.15 $2,245 - $4,796	-297 Reduced 20.5%	1,152 $18,000
Q1 2024 Apr 05, 2024	BUY	$7.96 - $12.37 $11,008 - $17,107	1,383 Added 2095.45%	1,449 $15,000
Q4 2023 Feb 01, 2024	SELL	$4.9 - $12.86 $1,092 - $2,867	-223 Reduced 77.16%	66 $1,000
Q3 2023 Oct 11, 2023	SELL	$7.0 - $11.26 $2,793 - $4,492	-399 Reduced 57.99%	289 $2,000
Q2 2023 Aug 03, 2023	SELL	$7.61 - $9.46 $3,447 - $4,285	-453 Reduced 39.7%	688 $6,000
Q1 2023 Apr 28, 2023	BUY	$8.83 - $17.61 $8,618 - $17,187	976 Added 591.52%	1,141 $10,000
Q4 2022 Feb 01, 2023	BUY	$10.88 - $20.05 $1,403 - $2,586	129 Added 358.33%	165 $2,000
Q3 2022 Oct 27, 2022	BUY	$16.06 - $26.39 $240 - $395	15 Added 71.43%	36 $1,000
Q2 2022 Jul 28, 2022	BUY	$20.49 - $39.72 $204 - $397	10 Added 90.91%	21 $0
Q1 2022 Apr 21, 2022	SELL	$28.19 - $46.6 $84 - $139	-3 Reduced 21.43%	11 $0
Q4 2021 Jan 31, 2022	BUY	$41.2 - $73.6 $576 - $1,030	14 New	14 $1,000

Others Institutions Holding CDNA

# of Institutions

217

Shares Held

53.3M

Call Options Held

53.5K

Put Options Held

23.9K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.03B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account